Legal & General is enhancing its critical illness (CI) product to include four new illnesses and wider definitions for eleven conditions.
Aviva paid out 1,499 critical illness (CI) claims during 2009, totalling almost £118m, with a 2% non disclosure rate, according to data released today.
Critical illness (CI) payouts are continuing to rise and non-disclosure rates are also improving, new figures show.
IFAs expecting a decade heavy with new protection offerings could be disappointed, as providers plan to focus on adviser education not "churning" products.
Challenges may vary. Runners may come and go as some fall and others enter the race. However, the group life insurance market is still one of the most cut throat and price competitive in the protection industry, writes Owain Thomas
How should an adviser assess which Critical Illness policy they should offer to a client? Specialist protection IFA Alan Lakey outlines a new approach to product selection...
The FSA has given advisers who sell individual long-term pure protection contracts under ICOBS until the end of the year to apply its rules on 'total premium' disclosure.
The FSA has issued four questions for the protection industry as part of its Consulation Paper 10/8.
Bupa is offering group critical illness (CI) claimants and their families access to Best Doctors with no increase in premiums.
Aviva has entered the group critical illness market with the unveiling of a new product.